🚀 VC round data is live in beta, check it out!
Indisa Valuation Multiples
Discover revenue and EBITDA valuation multiples for Indisa and similar public comparables like Fulgent Genetics, Myriad Genetics, Healius, Maravai LifeSciences and more.
Indisa Overview
About Indisa
Instituto de Diagnostico SA, through Clinica Indisa, provides medical and healthcare services. It offers clinical services in the areas of general surgery, traumatology, urology, maternity, dialysis, cardiovascular, odontology, gynecology and obstetrics, blood bank facility, maternity facility, critical patient unit, and various other medical-related services and facilities. Along with its subsidiaries, the company operates in the following segments; Hospitalization which generates maximum revenue and corresponds to services provided to patients who are hospitalized and spend days in bed; Outpatient corresponds to services that do not involve occupation of bed days; and Others corresponds to the parking rental and services category maintenance.
Founded
1961
HQ
Employees
3.1K
Website
Sectors
Financials (FY)
EV
$540M
Indisa Financials
Indisa reported last fiscal year revenue of $264M and EBITDA of $18M.
In the same fiscal year, Indisa generated $64M in gross profit, $18M in EBITDA, and $8M in net income.
Indisa P&L
In the most recent fiscal year, Indisa reported revenue of $264M and EBITDA of $18M.
Indisa expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $264M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $64M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 24% | XXX | XXX | XXX |
| EBITDA | — | XXX | $18M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 6% | XXX | XXX | XXX |
| Net Profit | — | XXX | $8M | XXX | XXX | XXX |
| Net Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $91M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Indisa Stock Performance
Indisa has current market cap of $428M, and enterprise value of $540M.
Market Cap Evolution
Indisa's stock price is $2.80.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $540M | $428M | (1.2%) | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIndisa Valuation Multiples
Indisa trades at 2.0x EV/Revenue multiple, and 29.6x EV/EBITDA.
Indisa Financial Valuation Multiples
As of March 7, 2026, Indisa has market cap of $428M and EV of $540M.
Equity research analysts estimate Indisa's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Indisa has a P/E ratio of 53.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $428M | XXX | $428M | XXX | XXX | XXX |
| EV (current) | $540M | XXX | $540M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 29.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 33.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 8.4x | XXX | XXX | XXX |
| P/E | — | XXX | 53.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 29.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Indisa Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Indisa Margins & Growth Rates
Indisa's revenue in the last fiscal year grew by 9%.
Indisa Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 133% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Indisa Public Comps
See public comps and valuation multiples for other Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fulgent Genetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Myriad Genetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Maravai LifeSciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Indisa M&A Activity
Indisa acquired XXX companies to date.
Last acquisition by Indisa was on XXXXXXXX, XXXXX. Indisa acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Indisa
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIndisa Investment Activity
Indisa invested in XXX companies to date.
Indisa made its latest investment on XXXXXXXX, XXXXX. Indisa invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Indisa
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Indisa
| When was Indisa founded? | Indisa was founded in 1961. |
| Where is Indisa headquartered? | Indisa is headquartered in Chile. |
| How many employees does Indisa have? | As of today, Indisa has over 3K employees. |
| Is Indisa publicly listed? | Yes, Indisa is a public company listed on Bolsa de Santiago. |
| What is the stock symbol of Indisa? | Indisa trades under INDISA ticker. |
| When did Indisa go public? | Indisa went public in 1982. |
| Who are competitors of Indisa? | Indisa main competitors are Fulgent Genetics, Myriad Genetics, Healius, Maravai LifeSciences. |
| What is the current market cap of Indisa? | Indisa's current market cap is $428M. |
| What is the current revenue of Indisa? | Indisa's last fiscal year revenue is $264M. |
| What is the current EV/Revenue multiple of Indisa? | Current revenue multiple of Indisa is 2.0x. |
| Is Indisa profitable? | No, Indisa is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.